{
    "nctId": "NCT04678544",
    "briefTitle": "Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients",
    "officialTitle": "A Randomized Controlled Trial to Evaluate Effectiveness of Cooling Cap to Prevent Permanent Chemotherapy-induced Alopecia Among Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Neoplasm, Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 170,
    "primaryOutcomeMeasure": "Permanent chemotherapy-induced alopecia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed breast cancer, stage I-III\n* Expected to receive 4 or 6 cycles of Adriamycin or Taxance of chemotherapy regimen as neoadjuvant or adjuvant chemotherapy with curative intent (e.g., AC, TC, or TCHP)\n\nExclusion Criteria:\n\n* Any other concurrent malignancy including hematological malignancies\n* Elevated liver enzymes or bilirubin defined as 3 times the upper limits of normal\n* Serum Albumin \\< 3.0\n* Subjects who are underweight (defined as a BMI \\< 17.5)\n* Subjects who have had previous chemotherapy exposure\n* Subjects with cold agglutinin disease or cold urticarial\n* Subject who had thyroid disease, diabetes or cardiac disease\n* Subject who had auto-immune disease\n* History of treatment due to alopecia\n* Subject who had scalp disease",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}